ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis

被引:0
|
作者
Ryota Nakanishi
Eiji Oki
Hirofumi Hasuda
Eiki Sano
Yu Miyashita
Akihiro Sakai
Naomichi Koga
Naotaka Kuriyama
Kentaro Nonaka
Yoshiaki Fujimoto
Tomoko Jogo
Kentaro Hokonohara
Qingjiang Hu
Yuichi Hisamatsu
Koji Ando
Yasue Kimura
Tomoharu Yoshizumi
Masaki Mori
机构
[1] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2986 / 2987
页数:1
相关论文
共 50 条
  • [31] Adjuvant oxaliplatin-based chemotherapy effect after treatment of colorectal hepatic metastasis
    Kang, Mee-Young
    Paik, Jin-Hee
    Ryu, Chun-Geun
    Hwang, Dae-Yong
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 101 (03) : 160 - 166
  • [32] Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment
    Kjersem, J. B.
    Ikdahl, T.
    Lingjaerde, O. C.
    Guren, T.
    Tveit, K. M.
    Kure, E. H.
    MOLECULAR ONCOLOGY, 2014, 8 (01) : 59 - 67
  • [33] CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy
    Qi, Wei
    Yang, Jing
    Zheng, Longbo
    Lu, Yun
    Liu, Ruiqing
    Ju, Yiheng
    Niu, Tianye
    Wang, Dongsheng
    MEDICAL PHYSICS, 2023, 50 (05) : 2705 - 2714
  • [34] Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy
    Ulrich-Pur, H
    Kornek, GV
    Fiebiger, W
    Gedlicka, C
    Raderer, M
    Lenauer, A
    Depisch, D
    Lang, F
    Pidlich, J
    Scheithauer, W
    ANNALS OF ONCOLOGY, 2001, 12 (09) : 1269 - 1272
  • [35] A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)
    Shoichi Hazama
    Yusuke Nakamura
    Hiroaki Tanaka
    Kosei Hirakawa
    Ko Tahara
    Ryoichi Shimizu
    Hiroaki Ozasa
    Ryuichi Etoh
    Fumiaki Sugiura
    Kiyotaka Okuno
    Takumi Furuya
    Taku Nishimura
    Koichiro Sakata
    Kazuhiko Yoshimatsu
    Hiroko Takenouchi
    Ryouichi Tsunedomi
    Yuka Inoue
    Shinsuke Kanekiyo
    Yoshitaro Shindo
    Nobuaki Suzuki
    Shigefumi Yoshino
    Hirokazu Shinozaki
    Akira Kamiya
    Hiroyuki Furukawa
    Takeharu Yamanaka
    Tomonobu Fujita
    Yutaka Kawakami
    Masaaki Oka
    Journal of Translational Medicine, 12
  • [36] Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
    Hamfjord, J.
    Guren, T. K.
    Dajani, O.
    Johansen, J. S.
    Glimelius, B.
    Sorbye, H.
    Pfeiffe, P.
    Lingjaerde, O. C.
    Tveit, K. M.
    Kure, E. H.
    Pallisgaard, N.
    Spindler, K-L G.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1088 - 1095
  • [37] Predictive Value of Circulating Tumor Cells in Prognosis of Stage III/IV Colorectal Cancer After oxaliplatin-based First-line Chemotherapy
    Yu, Jiazi
    Zhang, John
    Peng, Tao
    Fei, Zhenglei
    Jin, Liangbin
    Yang, Mian
    IN VIVO, 2022, 36 (02): : 806 - 813
  • [38] A phase II study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)
    Hazama, Shoichi
    Nakamura, Yusuke
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Tahara, Ko
    Shimizu, Ryoichi
    Ozasa, Hiroaki
    Etoh, Ryuichi
    Sugiura, Fumiaki
    Okuno, Kiyotaka
    Furuya, Takumi
    Nishimura, Taku
    Sakata, Koichiro
    Yoshimatsu, Kazuhiko
    Takenouchi, Hiroko
    Tsunedomi, Ryouichi
    Inoue, Yuka
    Kanekiyo, Shinsuke
    Shindo, Yoshitaro
    Suzuki, Nobuaki
    Yoshino, Shigefumi
    Shinozaki, Hirokazu
    Kamiya, Akira
    Furukawa, Hiroyuki
    Yamanaka, Takeharu
    Fujita, Tomonobu
    Kawakami, Yutaka
    Oka, Masaaki
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [39] Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy
    Ono, Tomojiro
    Ishida, Hideyuki
    Kumamoto, Kensuke
    Okada, Norimichi
    Ishibashi, Keiichiro
    ONCOLOGY LETTERS, 2012, 4 (05) : 905 - 909
  • [40] Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study
    Imai, Hiroo
    Saijo, Ken
    Komine, Keigo
    Ueta, Reio
    Numakura, Ryunosuke
    Wakayama, Shonosuke
    Umegaki, Sho
    Hiraide, Sakura
    Kawamura, Yoshifumi
    Kasahara, Yuki
    Ohuchi, Kota
    Takahashi, Masahiro
    Takahashi, Shin
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1259 - 1266